AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2025
Nov 28, 2025
34519_dirs_2025-11-28_128fd0c9-7abf-409b-941f-09b14bed9d18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-11-25
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | Common Stock $0.10 par value per share | P | 1633 | $4.76 | Acquired | 52720 | Direct |
| 2025-11-25 | Common Stock $0.10 par value per share | P | 1633 | $4.765 | Acquired | 4740 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock $0.10 par value per share | 73927 | Indirect |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23